“Achieving Depth of Response in Skin Clearance and Itch Relief With Lebrikizumab Is Associated With Minimal Impact of Atopic Dermatitis on Quality of Life”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 1, Jan. 2025, p. s516, https://doi.org/10.25251/skin.9.supp.516.